Cargando…
The neurotransmitter dopamine modulates vascular permeability in the endothelium
BACKGROUND: Vascular permeability factor/Vascular endothelial growth factor (VPF/VEGF), a multifunctional cytokine, is a potent inducer of vascular permeability, an important early step in angiogenesis. It is known that the neurotransmitter dopamine can inhibit VPF/VEGF mediated angiogenesis, in par...
Autores principales: | Bhattacharya, Resham, Sinha, Sutapa, Yang, Su-Ping, Patra, Chittaranjan, Dutta, Shamit, Wang, Enfeng, Mukhopadhyay, Debabrata |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516513/ https://www.ncbi.nlm.nih.gov/pubmed/18662404 http://dx.doi.org/10.1186/1750-2187-3-14 |
Ejemplares similares
-
VEGF neutralizing antibody increases the therapeutic efficacy of vinorelbine for renal cell carcinoma
por: Sinha, Sutapa, et al.
Publicado: (2010) -
Vascular Endothelial Growth Factor Receptor-1 Modulates Hypoxia-Mediated Endothelial Senescence and Cellular Membrane Stiffness via YAP-1 Pathways
por: Angom, Ramcharan Singh, et al.
Publicado: (2022) -
Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*
por: Bhattacharya, Resham, et al.
Publicado: (2008) -
Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer
por: Madamsetty, Vijay Sagar, et al.
Publicado: (2020) -
Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer
por: Pal, Krishnendu, et al.
Publicado: (2019)